Literature DB >> 6173480

Buscopan or glucagon for endoscopic cannulation of ampulla of vater?

B F Hannigan, A T Axon, S Avery, R P Thompson.   

Abstract

The number of intravenous injections of hyoscine-N-butylbromide (Buscopan) or glucagon required to maintain relaxation of the duodenum during endoscopic retrograde cholangiopancreatography (ERCP) were compared in a double blind trial of 55 patients. There was no significant difference in the number of injections. Serum amylase levels after the use of both relaxants were compared in 50 patients undergoing ERCP. No significant difference in the levels of hyperamylasaemia were found.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173480      PMCID: PMC1437371          DOI: 10.1177/014107688207500106

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  5 in total

Review 1.  ERCP.

Authors:  P B Cotton
Journal:  Gut       Date:  1977-04       Impact factor: 23.059

2.  Glucagon therapy in acute pancreatitis.

Authors:  J R Condon; M Knight; J L Day
Journal:  Br J Surg       Date:  1973-07       Impact factor: 6.939

3.  Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography.

Authors:  G Skude; L Wehlin; T Maruyama; J Ariyama
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

4.  Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases.

Authors:  M K Bilbao; C T Dotter; T G Lee; R M Katon
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  Glucagon therapy in acute pancreatitis. Report of a double-blind trial.

Authors:  H K Dürr; D Maroske; O Zelder; J C Bode
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

  5 in total
  3 in total

1.  Otilonium bromide as spasmolytic during endoscopic retrograde cholangiopancreatography.

Authors:  Ömer Karahan; Barış Sevinç; Ahmet Okuş; Serden Ay; Nergis Aksoy
Journal:  Surg Endosc       Date:  2014-11-01       Impact factor: 4.584

2.  The Efficacy and Safety of Low Dose versus Usual Dose of Hyoscine During Endoscopic Retrograde Cholangiopancreatography: A Randomized Clinical Trial.

Authors:  Hassan Salmanroghani; Massoud Mirvakili; Mahtabalsadat Mirjalili; Mahmud Baghbanian; Roham Salmanroghani
Journal:  Clin Pharmacol       Date:  2020-08-20

3.  Paradoxical Stimulatory Response of Remanent Sphincter of Oddi to Buscapina After Endoscopic Sphincterotomy.

Authors:  Zoltán Berger; Ana María Madrid S
Journal:  J Neurogastroenterol Motil       Date:  2021-10-30       Impact factor: 4.924

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.